g. bural Et Al. , "Evaluation of salivary gland functions with dynamic scintigraphy before and after fractioned low-dose (30 mCi) of I-131 ablative therapy in patients with differentiated thyroid carcinoma," Annual Congress of the European Association of Nuclear Medicine , vol.29, Viyana, Austria, pp.312, 2002
bural, g. Et Al. 2002. Evaluation of salivary gland functions with dynamic scintigraphy before and after fractioned low-dose (30 mCi) of I-131 ablative therapy in patients with differentiated thyroid carcinoma. Annual Congress of the European Association of Nuclear Medicine , (Viyana, Austria), 312.
bural, g., BOZ, A., ÇERİ, İ. O., AYDIN, F., yaylalı, o., YIDIZ, A., ... GÜNGÖR, A. F.(2002). Evaluation of salivary gland functions with dynamic scintigraphy before and after fractioned low-dose (30 mCi) of I-131 ablative therapy in patients with differentiated thyroid carcinoma . Annual Congress of the European Association of Nuclear Medicine (pp.312). Viyana, Austria
bural, gonca Et Al. "Evaluation of salivary gland functions with dynamic scintigraphy before and after fractioned low-dose (30 mCi) of I-131 ablative therapy in patients with differentiated thyroid carcinoma," Annual Congress of the European Association of Nuclear Medicine, Viyana, Austria, 2002
bural, gonca Et Al. "Evaluation of salivary gland functions with dynamic scintigraphy before and after fractioned low-dose (30 mCi) of I-131 ablative therapy in patients with differentiated thyroid carcinoma." Annual Congress of the European Association of Nuclear Medicine , Viyana, Austria, pp.312, 2002
bural, g. Et Al. (2002) . "Evaluation of salivary gland functions with dynamic scintigraphy before and after fractioned low-dose (30 mCi) of I-131 ablative therapy in patients with differentiated thyroid carcinoma." Annual Congress of the European Association of Nuclear Medicine , Viyana, Austria, p.312.
@conferencepaper{conferencepaper, author={gonca bural Et Al. }, title={Evaluation of salivary gland functions with dynamic scintigraphy before and after fractioned low-dose (30 mCi) of I-131 ablative therapy in patients with differentiated thyroid carcinoma}, congress name={Annual Congress of the European Association of Nuclear Medicine}, city={Viyana}, country={Austria}, year={2002}, pages={312} }